Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-02-26 | 2021-03-08 | 134814 |
APO-LEVOCARB-TAB 25MG/100MG | 25MG 100MG | TABLET | Resolved | 2021-02-26 | 2021-03-08 | 134817 |
APO-NAPROXEN | 250MG | TABLET | Resolved | 2021-02-26 | 2021-03-24 | 134820 |
APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2021-03-05 | 2021-05-26 | 135148 |
APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-03-05 | 2021-03-29 | 135162 |
APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2021-03-05 | 2021-06-21 | 135171 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2021-03-05 | 2021-05-17 | 135177 |
APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2021-03-05 | 2021-06-14 | 135181 |
APO-QUINAPRIL | 5MG | TABLET | Actual shortage | 2021-03-15 | 2021-10-29 | 135685 |
APO-QUINAPRIL | 10MG | TABLET | Actual shortage | 2021-03-15 | 2021-10-29 | 135689 |
APO-QUINAPRIL | 20MG | TABLET | Actual shortage | 2021-03-15 | 2021-12-03 | 135692 |
APO-QUINAPRIL | 40MG | TABLET | Actual shortage | 2021-03-15 | 2021-10-30 | 135695 |
APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-03-19 | 2021-04-12 | 136016 |
APO-IBUPROFEN | 400MG | TABLET | Resolved | 2021-03-19 | 2021-06-07 | 136019 |
APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2021-03-19 | 2021-03-30 | 136026 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-03-19 | 2021-05-03 | 136030 |
APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2021-03-19 | 2021-04-19 | 136044 |
APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2021-03-19 | 2021-05-03 | 136047 |
APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Resolved | 2021-03-26 | 2021-05-10 | 136403 |
APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2021-04-05 | 2021-05-17 | 136799 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |